Astellas' regenerative medicine research unit begins operations

04/1/2014 | PMLive.com (U.K.)

Astellas Pharma announced that its regenerative medicine unit has begun operations and will lead the company's research and development of cell-based therapies. Astellas has been working with Cytori Therapeutics on the use of fat-derived stem cells and has partnered with Switzerland's ClearPath Development on vaccines.

View Full Article in:

PMLive.com (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC